HK1011033A1 - Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase - Google Patents

Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Info

Publication number
HK1011033A1
HK1011033A1 HK98112163A HK98112163A HK1011033A1 HK 1011033 A1 HK1011033 A1 HK 1011033A1 HK 98112163 A HK98112163 A HK 98112163A HK 98112163 A HK98112163 A HK 98112163A HK 1011033 A1 HK1011033 A1 HK 1011033A1
Authority
HK
Hong Kong
Prior art keywords
inhibitors
human leukocyte
peptide derivatives
leukocyte elastase
trifluoromethyl ketone
Prior art date
Application number
HK98112163A
Other languages
English (en)
Inventor
Stephen John Pegg
George Joseph Sependa
Elwyn Peter Davies
Chris Allan Veale
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421550A external-priority patent/GB9421550D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HK1011033A1 publication Critical patent/HK1011033A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98112163A 1994-02-11 1998-11-20 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase HK1011033A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402680A GB9402680D0 (en) 1994-02-11 1994-02-11 Pyrrolidine derivatives
GB9421550A GB9421550D0 (en) 1994-10-26 1994-10-26 Heterocyclic derivative
PCT/GB1995/000242 WO1995021855A1 (en) 1994-02-11 1995-02-07 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Publications (1)

Publication Number Publication Date
HK1011033A1 true HK1011033A1 (en) 1999-07-02

Family

ID=26304315

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112163A HK1011033A1 (en) 1994-02-11 1998-11-20 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Country Status (20)

Country Link
US (3) US5739157A (xx)
EP (1) EP0743953B1 (xx)
JP (1) JP3416142B2 (xx)
CN (1) CN1140455A (xx)
AT (1) ATE174034T1 (xx)
AU (1) AU692515B2 (xx)
CA (1) CA2180006A1 (xx)
DE (1) DE69506380T2 (xx)
DK (1) DK0743953T3 (xx)
ES (1) ES2125004T3 (xx)
FI (1) FI963132A (xx)
GB (1) GB9402680D0 (xx)
HK (1) HK1011033A1 (xx)
IL (1) IL112613A (xx)
MX (1) MX9603291A (xx)
NO (1) NO313882B1 (xx)
NZ (1) NZ279265A (xx)
TW (1) TW414801B (xx)
WO (1) WO1995021855A1 (xx)
YU (1) YU7195A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
US5942536A (en) * 1995-10-10 1999-08-24 Eli Lilly And Company N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists
TR199801935T2 (xx) * 1996-03-28 1999-03-22 Glaxo Group Limited N�trofil elastaz inhibit�rleri olarak pirolopirolon t�revleri.
GB9719187D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
CA2498052C (en) 2002-09-10 2011-05-17 Bayer Healthcare Ag Heterocyclic derivatives
CA2556463C (en) 2004-02-19 2012-08-14 Bayer Healthcare Ag Dihydropyridinone derivatives
DE102005037791A1 (de) * 2005-08-10 2007-02-15 Ernst-Moritz-Arndt Universität Greifswald Verwendung von spezifischen Trifluormethylketonen zur Vorbeugung und Behandlung einer Pankreatitis
CA2669917A1 (en) * 2006-11-17 2008-05-22 Dawn M. George Aminopyrrolidines as chemokine receptor antagonists
CN103226756A (zh) * 2013-04-28 2013-07-31 文俊 工艺品生产过程的工艺制作及生产过程的记录方法和系统
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives

Also Published As

Publication number Publication date
YU7195A (sh) 1998-09-18
JPH09508902A (ja) 1997-09-09
TW414801B (en) 2000-12-11
ES2125004T3 (es) 1999-02-16
US5739157A (en) 1998-04-14
FI963132A0 (fi) 1996-08-09
US5907043A (en) 1999-05-25
MX9603291A (es) 1997-02-28
EP0743953A1 (en) 1996-11-27
EP0743953B1 (en) 1998-12-02
NO963329D0 (no) 1996-08-09
ATE174034T1 (de) 1998-12-15
NO963329L (no) 1996-10-09
CA2180006A1 (en) 1995-08-17
AU1583995A (en) 1995-08-29
DE69506380D1 (de) 1999-01-14
DK0743953T3 (da) 1999-08-16
WO1995021855A1 (en) 1995-08-17
GB9402680D0 (en) 1994-04-06
CN1140455A (zh) 1997-01-15
FI963132A (fi) 1996-08-09
JP3416142B2 (ja) 2003-06-16
US6037363A (en) 2000-03-14
NZ279265A (en) 1998-01-26
NO313882B1 (no) 2002-12-16
IL112613A (en) 2000-02-29
DE69506380T2 (de) 1999-05-06
AU692515B2 (en) 1998-06-11
IL112613A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
HK1011033A1 (en) Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
DE69314169D1 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
NO943910L (no) Laktam-peptider med HLE-hemmende virkning
DE69308291D1 (de) Lactam Dipeptide mit HLE inhibierende Aktivität.
EP0652892A1 (en) LACTAM DIPEPTIDES WITH INHIBITING ACTIVITY FOR HUMAN LEUKOCYTE ELASTASE.
ATE171191T1 (de) Fluorenthaltende dipeptide als inhibitoren gegen elastase menschliches leukocyten
AU622316B2 (en) Fluoro-amide derivatives
GB8910550D0 (en) Substituted amides
MX9705231A (es) Derivados de prolina utiles como inhibidores de elastasa leucocito humano.
RU94045847A (ru) Лактамовые дипептиды, проявляющие ингибирующее действие на эластазу лейкоцитов человека, промежуточные соединения, способ получения, фармацевтическая композиция

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040207

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)